Clinical Trial Update: Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients

View source ↗

Summary

Clinical trial update for the Ultimaster Nagomi Sirolimus-Eluting Coronary Stent System in complex PCI patients; the study status is Active Not Recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Occlusion
• Ischemic Heart Disease

Drugs mentioned

• Ultimaster Nagomi Sirolimus-Eluting Coronary Stent System (Sirolimus-eluting coronary stent)

Snippet

Sponsor: Terumo Europe N.V. | Conditions: Cardiovascular Disease, Coronary Artery Occlusion | Status: ACTIVE_NOT_RECRUITING